Markus Berninger
Phone:+49 89 290919-30Fax:+49 89 290919-98

Knowledge Transfer


Max Planck Society grants technology for cancer therapy

July 11, 2017
Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center announce cancer research collaboration [more]

New production process makes medications affordable even for poorer countries

July 11, 2017
FluxPharm licenses process for the cost-effective production of active pharmaceutical ingredients [more]
Teaser image horizontal 1493993004

Teaching robots to see what they do

May 05, 2017
Max Planck Innovation signs agreement with Lula Robotics to develop technology for autonomous robotics [more]
Teaser image horizontal 1491825350

PreOmics granted licence for proteomics technique

April 10, 2017
A technique developed by the Max Planck Institute of Biochemistry shortens the time required to prepare samples for mass spectrometry [more]
Teaser image horizontal 1479395166

Vaxxilon named “Science Start-Up of the Year 2016”

November 17, 2016
Vaxxilon is developing carbohydrate-based vaccine candidates that should make vaccinations against bacterial infections cheaper in the future. [more]
Teaser image horizontal 1476169578

Optogenetics for the search for active substances

October 11, 2016
License agreement between Max Planck Innovation and Photoswitch Biosciences forms the basis for new platform for identifying and testing novel drug candidates [more]
Teaser image horizontal 1466774455

Abberior Instruments licenses next generation STED-technology

June 24, 2016
Protected STED will improve microscopic imaging of living cells [more]
loading content